Low Dose Cyclosporin and Methotrexate Therapy in Diabetes

Completed · Not applicable

Conditions studied: Type 1 Diabetes Mellitus

In brief

The purpose of this study is to determine whether treatment with low dose cyclosporin and methotrexate can inhibit the development of new onset diabetes mellitus

Key facts

Study ID

NCT00905073

Run by

Georgetown University

People needed

8

Starts

1990-02-01

Expected to finish

1994-06-01

Last updated by the study team

2011-04-13

Who can join

Age: 8 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of Type1 diabetes mellitus and be obtaining insulin therapy for less than 4 weeks

You may not qualify if…

• Ketoacidosis
• Body weight over 110% of ideal weight
• Condition where immunosuppression is contraindicated
• Abnormal liver or renal function tests

Where it is running

• Georgetown University — Washington D.C., District of Columbia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.